Loading provider…
Loading provider…
Cardiovascular Disease Physician in Boston, MA
NPI: 1548227960Primary Practice Location
BRIGHAM AND WOMEN'S HOSPITAL
75 Francis St, Boston, MA
Primary Employer
Brigham & Womens Physicians Organization Inc
brighamandwomens.org
HQ Phone
Get MD Christopher's Phone Numberphone_androidMobile
Get MD Christopher's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 93010Routine electrocardiogram (EKG) using at least 12 leads with interpretation and report | 915 | 1,127 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 207 | 239 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 66 | 71 |
| 4 | 99204New patient office or other outpatient visit, 45-59 minutes | 50 | 50 |
| 5 | 93018Exercise or drug-induced heart and blood vessel stress test with EKG monitoring, physician interpretation and report | 41 | 41 |
Lead Sponsor: Lexicon Pharmaceuticals
Collaborators: Sanofi
Intervention / Treatment: DRUG: Placebo, DRUG: Sotagliflozin
Lead Sponsor: Sanofi
Collaborators: Regeneron Pharmaceuticals
Intervention / Treatment: DRUG: Lipid Modifying Therapy (LMT), DRUG: Alirocumab, DRUG: Ezetimibe, DRUG: Placebo (for alirocumab), DRUG: Placebo (for ezetimibe)
Lead Sponsor: Sanofi
Collaborators: Regeneron Pharmaceuticals
Intervention / Treatment: DRUG: Fenofibrate, DRUG: Alirocumab, DRUG: Ezetimibe, DRUG: Ezetimibe Placebo